GRIN2B (Glutamate receptor) variants and mutations
GRIN2B (also known as Glutamate receptor) is a human protein-coding gene encoding a glutamate receptor protein. The GluN2B subunit of NMDA glutamate receptors, ion channels that mediate excitatory signaling in the brain. Pathogenic variants can disrupt neuronal development and cause neurodevelopmental disorders, sometimes with epilepsy. This analysis covers 1 GRIN2B variants and mutations. Disease context includes intellectual disability, autosomal dominant 6, developmental and epileptic encephalopathy, 27, and Alzheimer disease. Example GRIN2B variants include G377R.
Variant analysis overview
- Gene: GRIN2B
- Protein: Glutamate receptor
- UniProt accession: A0A8D9PHB2
- Organism: Homo sapiens
- Variants analyzed: 1
- Variant scope: all variants
- Completed: 2026-09-12
Variant and mutation evidence
- Variant composition: 1 substitution
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: intellectual disability, autosomal dominant 6, developmental and epileptic encephalopathy, 27, Alzheimer disease, Parkinson disease, complex neurodevelopmental disorder, infantile spasms, influenza, infection, major depressive disorder, depressive disorder, alcohol dependence, epilepsy.
Protein structure and variant hotspots
- Protein features: 4 transmembrane segments; 2 domains; 5 binding sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Diseases linked to GRIN2B
- Developmental and epileptic encephalopathy genes and variants
- Alzheimer disease genes and variants
- Complex neurodevelopmental disorder genes and variants
- Epilepsy genes and variants
- Spasms genes and variants
- Parkinson disease genes and variants
- Developmental disorder genes and variants
- Dementia genes and variants
- Craniosynostosis genes and variants
Notable GRIN2B variants
Examples include G377R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
Public GRIN2B analysis runs
- GRIN2B analysis run — GRIN2B (1 variants) — completed 2026-09-12
- GRIN2B analysis run — GRIN2B (2,202 variants) — completed 2026-09-12
- GRIN2B analysis run — GRIN2B (2,202 variants) — completed 2026-09-12
- GRIN2B analysis run — GRIN2B (1 variants) — completed 2026-09-12
- GRIN2B analysis run — GRIN2B (184 variants) — completed 2026-09-07
- GRIN2B analysis run — GRIN2B (2,433 variants) — completed 2026-08-20